Webinar: Critical Imaging Risks In GLP-1 And Neurology Studies
Available on Demand
Clinical trials in GLP-1 and neurology are rapidly evolving, and imaging is increasingly crucial for evaluating efficacy and safety. However, the challenges associated with imaging are often ignored until they affect trial timelines, costs, and outcomes.
This expert-led discussion explores:
- Early indicators of imaging challenges—what we’re seeing now in active trials
- Preclinical insights—how early-stage protocol development can mitigate risk in later phases
- Therapeutic area trends—where imaging requirements are expanding in trials
- Hidden risks in trial imaging—what sponsors and CROs may be missing
This webinar is essential for clinical operations leaders looking to mitigate risk and protect ROI across therapeutic areas. Watch now to stay ahead of the curve!
Watch the Webinar Now!
Get deep insight into the importance of leveraging preclinical insights to inform trial design and strategically plan for the growing demands of imaging to enhance trial outcomes and regulatory compliance
Key learning objectives:
- Early Identification of Imaging Risks Prevents Costly Delays
- Imaging-related challenges in GLP-1 and neurology trials often go unnoticed until they disrupt timelines and budgets. Recognizing early indicators in active trials can help sponsors and CROs mitigate risks before they escalate.
- Preclinical Insights Can Impact Trial Design
- Incorporating imaging insights in early-stage protocol development improves decision-making in later trial phases. Understanding preclinical data trends allows for proactive adjustments that enhance trial efficiency and patient safety.
- Expanding Imaging Requirements Demands Strategic Planning
- Therapeutic area trends indicate a growing reliance on imaging across clinical trials. Sponsors who stay ahead of evolving requirements can optimize trial outcomes and ensure regulatory compliance.